1
|
Silva RP, Carvalho LAC, Patricio ES, Bonifacio JPP, Chaves-Filho AB, Miyamoto S, Meotti FC. Identification of urate hydroperoxide in neutrophils: A novel pro-oxidant generated in inflammatory conditions. Free Radic Biol Med 2018; 126:177-186. [PMID: 30118829 DOI: 10.1016/j.freeradbiomed.2018.08.011] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/19/2018] [Revised: 08/09/2018] [Accepted: 08/11/2018] [Indexed: 12/13/2022]
Abstract
Uric acid is the final product of purine metabolism in humans and is considered to be quantitatively the main antioxidant in plasma. In vitro studies showed that the oxidation of uric acid by peroxidases, in presence of superoxide, generates urate free radical and urate hydroperoxide. Urate hydroperoxide is a strong oxidant and might be a relevant intermediate in inflammatory conditions. However, the identification of urate hydroperoxide in cells and biological samples has been a challenge due to its high reactivity. By using mass spectrometry, we undoubtedly demonstrated the formation of urate hydroperoxide and its corresponding alcohol, hydroxyisourate during the respiratory burst in peripheral blood neutrophils and in human leukemic cells differentiated in neutrophils (dHL-60). The respiratory burst was induced by phorbol myristate acetate (PMA) and greatly increased oxygen consumption and superoxide production. Both oxygen consumption and superoxide production were further augmented by incubation with uric acid. Conversely, uric acid significantly decreased the levels of HOCl, probably because of the competition with chloride by the catalysis of myeloperoxidase. In spite of the decrease in HOCl, the overall oxidative status, measured by GSH/GSSG ratio, was augmented in the presence of uric acid. In summary, the present results support the formation of urate hydroperoxide, a novel oxidant in neutrophils oxidative burst. Urate hydroperoxide is a strong oxidant and alters the redox balance toward a pro-oxidative environment. The production of urate hydroperoxide in inflammatory conditions could explain, at least in part, the harmful effect associated to uric acid.
Collapse
Affiliation(s)
- Railmara P Silva
- Departamento de Bioquímica, Instituto de Química (IQUSP), Universidade de São Paulo, São Paulo, SP, Brazil
| | - Larissa A C Carvalho
- Departamento de Bioquímica, Instituto de Química (IQUSP), Universidade de São Paulo, São Paulo, SP, Brazil
| | - Eliziane S Patricio
- Departamento de Bioquímica, Instituto de Química (IQUSP), Universidade de São Paulo, São Paulo, SP, Brazil
| | - João P P Bonifacio
- Departamento de Bioquímica, Instituto de Química (IQUSP), Universidade de São Paulo, São Paulo, SP, Brazil
| | - Adriano B Chaves-Filho
- Departamento de Bioquímica, Instituto de Química (IQUSP), Universidade de São Paulo, São Paulo, SP, Brazil
| | - Sayuri Miyamoto
- Departamento de Bioquímica, Instituto de Química (IQUSP), Universidade de São Paulo, São Paulo, SP, Brazil
| | - Flavia C Meotti
- Departamento de Bioquímica, Instituto de Química (IQUSP), Universidade de São Paulo, São Paulo, SP, Brazil.
| |
Collapse
|
2
|
Carvalho LAC, Lopes JPPB, Kaihami GH, Silva RP, Bruni-Cardoso A, Baldini RL, Meotti FC. Uric acid disrupts hypochlorous acid production and the bactericidal activity of HL-60 cells. Redox Biol 2018; 16:179-188. [PMID: 29510342 PMCID: PMC5952876 DOI: 10.1016/j.redox.2018.02.020] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2018] [Revised: 02/05/2018] [Accepted: 02/19/2018] [Indexed: 12/12/2022] Open
Abstract
Uric acid is the end product of purine metabolism in humans and is an alternative physiological substrate for myeloperoxidase. Oxidation of uric acid by this enzyme generates uric acid free radical and urate hydroperoxide, a strong oxidant and potentially bactericide agent. In this study, we investigated whether the oxidation of uric acid and production of urate hydroperoxide would affect the killing activity of HL-60 cells differentiated into neutrophil-like cells (dHL-60) against a highly virulent strain (PA14) of the opportunistic pathogen Pseudomonas aeruginosa. While bacterial cell counts decrease due to dHL-60 killing, incubation with uric acid inhibits this activity, also decreasing the release of the inflammatory cytokines interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF- α). In a myeloperoxidase/Cl-/H2O2 cell-free system, uric acid inhibited the production of HOCl and bacterial killing. Fluorescence microscopy showed that uric acid also decreased the levels of HOCl produced by dHL-60 cells, while significantly increased superoxide production. Uric acid did not alter the overall oxidative status of dHL-60 cells as measured by the ratio of reduced (GSH) and oxidized (GSSG) glutathione. Our data show that uric acid impairs the killing activity of dHL-60 cells likely by competing with chloride by myeloperoxidase catalysis, decreasing HOCl production. Despite diminishing HOCl, uric acid probably stimulates the formation of other oxidants, maintaining the overall oxidative status of the cells. Altogether, our results demonstrated that HOCl is, indeed, the main relevant oxidant against bacteria and deviation of myeloperoxidase activity to produce other oxidants hampers dHL-60 killing activity. Uric acid decreased microbicide activity and release of cytokines by dHL-60 cells. Uric acid decreased HOCl in cells and in the myeloperoxidase/Cl-/H2O2 system. Uric acid induces a pro-oxidant redox imbalance. HOCl is crucial for Pseudomonas aeruginosa killing by dHL-60.
Collapse
Affiliation(s)
- Larissa A C Carvalho
- Departamento de Bioquímica, Instituto de Química (IQUSP), Universidade de São Paulo, São Paulo, SP, Brazil
| | - João P P B Lopes
- Departamento de Bioquímica, Instituto de Química (IQUSP), Universidade de São Paulo, São Paulo, SP, Brazil
| | - Gilberto H Kaihami
- Departamento de Bioquímica, Instituto de Química (IQUSP), Universidade de São Paulo, São Paulo, SP, Brazil
| | - Railmara P Silva
- Departamento de Bioquímica, Instituto de Química (IQUSP), Universidade de São Paulo, São Paulo, SP, Brazil
| | - Alexandre Bruni-Cardoso
- Departamento de Bioquímica, Instituto de Química (IQUSP), Universidade de São Paulo, São Paulo, SP, Brazil
| | - Regina L Baldini
- Departamento de Bioquímica, Instituto de Química (IQUSP), Universidade de São Paulo, São Paulo, SP, Brazil
| | - Flavia C Meotti
- Departamento de Bioquímica, Instituto de Química (IQUSP), Universidade de São Paulo, São Paulo, SP, Brazil.
| |
Collapse
|
3
|
Affiliation(s)
- I F Benzie
- a Department of Health Sciences , The Hong Kong Polytechnic University , Kowloon , Hong Kong
| | - J J Strain
- b Human Nutrition Research Group , University of Ulster at Coleraine , Northern Ireland
| |
Collapse
|
4
|
Stamp LK, Turner R, Khalilova IS, Zhang M, Drake J, Forbes LV, Kettle AJ. Myeloperoxidase and oxidation of uric acid in gout: implications for the clinical consequences of hyperuricaemia. Rheumatology (Oxford) 2014; 53:1958-65. [PMID: 24899662 DOI: 10.1093/rheumatology/keu218] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Abstract
OBJECTIVES The aims of this study were to establish whether, in patients with gout, MPO is released from neutrophils and urate is oxidized to allantoin and if these effects are attenuated by allopurinol. METHODS MPO, urate, allantoin and oxypurinol were measured in plasma from 54 patients with gout and 27 healthy controls. Twenty-three patients had acute gout, 13 of whom were receiving allopurinol, and 31 had intercritical gout, 20 of whom were receiving allopurinol. Ten additional gout patients had samples collected before and after 4 weeks of allopurinol. RESULTS Plasma MPO and its specific activity were higher (P < 0.05) in patients with acute gout not receiving allopurinol compared with controls. MPO protein in patients' plasma was related to urate concentration (r = 0.5, P < 0.001). Plasma allantoin was higher (P < 0.001) in all patient groups compared with controls. In controls and patients not receiving allopurinol, allantoin was associated with plasma urate (r = 0.62, P < 0.001) and MPO activity (r = 0.45, P < 0.002). When 10 patients were treated with allopurinol, it lowered their plasma urate and allantoin (P = 0.002). In all patients receiving allopurinol, plasma allantoin was related to oxypurinol (r = 0.65, P < 0.0001). Oxypurinol was a substrate for purified MPO that enhanced the oxidation of urate. CONCLUSION Increased concentrations of urate in gout lead to the release of MPO from neutrophils and the oxidation of urate. Products of MPO and reactive metabolites of urate may contribute to the pathology of gout and hyperuricaemia. At low concentrations, oxypurinol should reduce inflammation, but high concentrations may contribute to oxidative stress.
Collapse
Affiliation(s)
- Lisa K Stamp
- Department of Medicine, Department of Pathology, Centre for Free Radical Research, University of Otago, and Clinical Pharmacology Canterbury Health Laboratories, Christchurch, New Zealand
| | - Rufus Turner
- Department of Medicine, Department of Pathology, Centre for Free Radical Research, University of Otago, and Clinical Pharmacology Canterbury Health Laboratories, Christchurch, New Zealand
| | - Irada S Khalilova
- Department of Medicine, Department of Pathology, Centre for Free Radical Research, University of Otago, and Clinical Pharmacology Canterbury Health Laboratories, Christchurch, New Zealand
| | - Mei Zhang
- Department of Medicine, Department of Pathology, Centre for Free Radical Research, University of Otago, and Clinical Pharmacology Canterbury Health Laboratories, Christchurch, New Zealand
| | - Jill Drake
- Department of Medicine, Department of Pathology, Centre for Free Radical Research, University of Otago, and Clinical Pharmacology Canterbury Health Laboratories, Christchurch, New Zealand
| | - Louisa V Forbes
- Department of Medicine, Department of Pathology, Centre for Free Radical Research, University of Otago, and Clinical Pharmacology Canterbury Health Laboratories, Christchurch, New Zealand
| | - Anthony J Kettle
- Department of Medicine, Department of Pathology, Centre for Free Radical Research, University of Otago, and Clinical Pharmacology Canterbury Health Laboratories, Christchurch, New Zealand.
| |
Collapse
|
5
|
Trevisan G, Hoffmeister C, Rossato MF, Oliveira SM, Silva MA, Ineu RP, Guerra GP, Materazzi S, Fusi C, Nassini R, Geppetti P, Ferreira J. Transient Receptor Potential Ankyrin 1 Receptor Stimulation by Hydrogen Peroxide Is Critical to Trigger Pain During Monosodium Urate-Induced Inflammation in Rodents. ACTA ACUST UNITED AC 2013; 65:2984-95. [DOI: 10.1002/art.38112] [Citation(s) in RCA: 59] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2013] [Accepted: 07/25/2013] [Indexed: 01/13/2023]
Affiliation(s)
| | | | | | | | | | - Rafael P. Ineu
- Federal University of Santa Maria; Santa Maria, RS Brazil
| | - Gustavo P. Guerra
- Federal University of Technology of Paraná, Medianeira Campus; Medianeira, PR Brazil
| | | | | | | | | | - Juliano Ferreira
- Federal University of Santa Maria; Santa Maria, RS Brazil
- Federal University of Santa Catarina; Florianópolis, SC Brazil
| |
Collapse
|
6
|
Bondarenko TI, Maiboroda EA, Mikhaleva II, Prudchenko IA. Mechanism of geroprotective action of delta-sleep inducing peptide. ADVANCES IN GERONTOLOGY 2012. [DOI: 10.1134/s2079057011040035] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
7
|
Neutrophil myeloperoxidase: soldier and statesman. Arch Immunol Ther Exp (Warsz) 2011; 60:43-54. [PMID: 22143159 DOI: 10.1007/s00005-011-0156-8] [Citation(s) in RCA: 80] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2011] [Accepted: 10/05/2011] [Indexed: 01/15/2023]
Abstract
Myeloperoxidase (MPO) is a major protein constituent of the primary granules of vertebrate neutrophils. It catalyses the hydrogen peroxide-mediated oxidation of halide ions to hypohalous acids, especially HOCl. These reactive oxygen species can participate in a variety of secondary reactions, leading to modifications of amino acids and many types of biological macromolecules. The classic paradigm views MPO as a component of the phagocyte oxygen-dependent intracellular microbicidal system, and thus an important arm of the effector phase of innate immune responses. However, the limited immunodeficiency associated with lack of MPO in mouse and human models has challenged this paradigm. In this review we examine more recent information on the interaction between MPO, its bioreactive reaction products, and targets within the inflammatory microenvironment. We propose that two assumptions of the current model may require revisiting. First, many important targets of MPO modification are extracellular, rather than present only within the phagolysosome, such as various components of neutrophil extracellular traps. Second, we suggest that the pro-inflammatory pathological role of MPO may be a particular feature of chronic inflammation. In the physiological setting of acute neutrophil-mediated inflammation MPO may also form part of a negative feedback loop which down-regulates inflammation, limits tissue damage, and facilitates the switch from innate to adaptive immunity. This different perspective on this well-studied enzyme may usefully inform further research into its function in health and disease.
Collapse
|
8
|
Abstract
Uric acid, or more correctly (at physiological pH values), its monoanion urate, is traditionally considered to be a metabolically inert end-product of purine metabolism in man, without any physiological value. However, this ubiquitous compound has proven to be a selective antioxidant, capable especially of reaction with hydroxyl radicals and hypochlorous acid, itself being converted to innocuous products (allantoin, allantoate, glyoxylate, urea, oxalate). There is now evidence for such processes not only in vitro and in isolated organs, but also in the human lung in vivo. Urate may also serve as an oxidisable cosubstrate for the enzyme cyclooxygenase. As shown for the coronary system, a major site of production of urate is the microvascular endothelium, and there is generally a net release of urate from the human myocardium in vivo. In isolated organ preparations, urate protects against reperfusion damage induced by activated granulocytes, cells known to produce a variety of radicals and oxidants. Intriguingly, urate prevents oxidative inactivation of endothelial enzymes (cyclooxygenase, angiotensin converting enzyme) and preserves the ability of the endothelium to mediate vascular dilatation in the face of oxidative stress, suggesting a particular relationship between the site of urate formation and the need for a biologically potent radical scavenger and antioxidant.
Collapse
Affiliation(s)
- B F Becker
- Department of Physiology, University of Munich, Germany
| |
Collapse
|